• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Gender mismatch linked with autoimmune disease in chronic graft-vs-host disease

byShirin BajajandAdam Whittington
September 16, 2014
in Dermatology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with chronic graft-vs-host disease (CGVHD) after allogeneic hematopoietic stem cell transplantation (AHSCT) were more likely to develop cutaneous autoimmune diseases when there was female donor to male recipient sex mismatch or if the patient had Anticardiolipin (ACA) IgG antibodies.                                           

2. In patients with CGVHD, there was no significant association between indication for transplant, CGVHD duration, intensity of immunosuppressive therapy, HLA mismatch, or relation between recipient/donor, and risk of development of vitiligo or alopecia areata.

Evidence Rating Level: 3 (Average)

Study Rundown: CGVHD is a common complication after AHSCT. The cutaneous manifestations of CGVHD can often mimic autoimmune processes. Furthermore, case reports have elucidated a possible relationship between those patients who develop CGVHD after AHSCT and the subsequent development of cutaneous autoimmune diseases such as vitiligo or alopecia areata. However, because this relationship is not well understood, the authors sought to better understand the risk factors and associations between cutaneous autoimmune diseases and CGVHD. The results showed increased risk of developing vitiligo and alopecia areata in those transplants that had donor to recipient sex mismatch, particularly female donor to male recipient; however the results were limited by the very small subset of patients, likely due to the rare nature of these diseases.

Click to read the study in JAMA Dermatology

Relevant Reading: Amelanocytic Anhidrotic Alopecia Areata-like Phenotype After Allogeneic Hematopoietic Cell Transplant

In-Depth [cross-sectional study]: Of 282 patients with CGVHD after AHSCT, 13 patients were found to have vitiligo, 1 had alopecia areata, and 1 had both vitiligo and alopecia areata. These 15 patients, mostly male (66.7%), of median age 38 were identified and demographics, laboratory parameters, and CGVHD characteristics were collected. 64.29% of these patients had female donor to male recipient gender mismatch (p=.003), Of note, 14 of 15 patients who developed cutaneous autoimmune disease, with known donor sex, had a female donor. While anti-nuclear auto-antibodies and rheumatoid factor were both frequently found in these patients, the only statistically significant autoantibody association that was significant on multivariate analysis was ACA-IgG (4 of 15, 26.67%, P=.03).

RELATED REPORTS

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

More from this author: Tech-aided surveillance of patients at high risk for melanoma aids early diagnosis, Indoor tanning linked to high skin cancer risk in US and abroad, Free drug samples may alter prescription habits of dermatologists, Atopic dermatitis may be more persistent than previously understood

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: autologous stem cell transplantationgraft versus hoststem cells
Previous Post

Unexpected delivery outcomes associated with postpartum depression

Next Post

Thoracic radiotherapy improves survival in small-cell lung cancer patients

RelatedReports

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children
StudyGraphics

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

February 17, 2022
#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft
StudyGraphics

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

October 28, 2021
#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients
StudyGraphics

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

June 25, 2021
#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma
StudyGraphics

#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma

January 28, 2021
Next Post
Thoracic radiotherapy improves survival in small-cell lung cancer patients

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Spinal manipulation therapy effective for back-related leg pain

Spinal manipulation therapy effective for back-related leg pain

Dual PDE3/PDE4 inhibitor may be effective treatment for asthma and COPD

Improved COPD outcomes with combined long-acting beta-agonist and inhaled steroid therapy

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
  • Aspirin thromboprophylaxis noninferior to low-molecular-weight heparin in patients with fractures
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options